Press Releases Titan Pharmaceuticals, Inc.

Equities

TTNP

US8883147055

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-20 pm EDT			5-day change	1st Jan Change
6.45 ^USD	+1.74%		-4.36%	-21.82%

Apr. 01	Titan Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 26	Titan Pharmaceuticals Regains Compliance With Nasdaq Listing Rule	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Titan Pharmaceuticals: Q1 Earnings Snapshot	May. 15	AQ
Titan Pharmaceuticals : Non-Reliance on Previously Issued Financial Report - Form 8-K	Apr. 01	PU
Titan Pharmaceuticals : Private Placement - Form 8-K	Mar. 21	PU
Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria	Jan. 25	AQ
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - December 28, 2023	Dec. 29	AQ
Titan Pharmaceuticals Announces Reverse Stock Split and Ratio	Dec. 28	AQ
Titan Pharmaceuticals: Q3 Earnings Snapshot	Nov. 14	AQ
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors	23-10-16	AQ
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock	23-09-18	AQ
TITAN PHARMACEUTICALS : UNAUDITED PRO FORMA CONDENSED FINANCIAL INFORMATION - Form 8-K	23-09-08	PU
Titan Pharmaceuticals: Q2 Earnings Snapshot	23-08-15	AQ
Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets	23-07-27	AQ
TITAN PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Shareholder Director Nominations, Financial Statements and Exhibits (form 8-K)	23-04-11	AQ
TITAN PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-31	AQ
Vivakor Announces New Board of Directors	23-03-23	AQ
TITAN PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-22	AQ
TITAN PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-03	AQ
TITAN PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	23-02-09	AQ
TITAN PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits (form 8-K)	23-01-06	AQ
TITAN PHARMACEUTICALS INC : Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Titan Pharmaceuticals, Inc.

Equities

TTNP

US8883147055

Press Releases

Filters